PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that Dr. John Rothman, EVP of Science & Operations at Advaxis, will be chairing and speaking at the morning session of the 2012 World Immunotherapy Online Symposium Series, produced by Target Meeting, on April 27, 2012 at 9am EST.
